Literature DB >> 7480436

Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS.

T Kato1, T Shioiri, J Murashita, H Hamakawa, Y Takahashi, T Inubushi, S Takahashi.   

Abstract

High energy phosphate metabolites were measured using phase-encoded in vivo phosphorus-31 magnetic resonance spectroscopy (31P-MRS) in both the left and right frontal lobes of 25 patients with bipolar disorder. Eleven patients were examined in the depressive state, 12 in the manic state, and 21 in the euthymic state. Twenty-one age-matched normal volunteers were also examined. The phosphocreatine (PCr) peak area percentage in the left frontal lobe in the patients in the depressive state was decreased compared with that in the normal controls. It was significantly negatively correlated with the Hamilton Rating Scale for Depression score evaluated at the time of 31P-MRS examination. The PCr peak area percentage in the right frontal lobe in the patients in the manic and the euthymic states was decreased compared with that in the controls. These results are compatible with previous reports describing reduction of glucose metabolism in the left frontal lobe in depressive patients with bipolar disorder and trait-dependent right hemisphere dysfunction in bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7480436     DOI: 10.1017/s003329170003347x

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  16 in total

1.  Decreased brain PME/PDE ratio in bipolar disorder: a preliminary (31) P magnetic resonance spectroscopy study.

Authors:  Xian-Feng Shi; Paul J Carlson; Young-Hoon Sung; Kristen K Fiedler; Lauren N Forrest; Tracy L Hellem; Rebekah S Huber; Seong-Eun Kim; Chun Zuo; Eun-Kee Jeong; Perry F Renshaw; Douglas G Kondo
Journal:  Bipolar Disord       Date:  2015-10-19       Impact factor: 6.744

2.  Frontal lobe bioenergetic metabolism in depressed adolescents with bipolar disorder: a phosphorus-31 magnetic resonance spectroscopy study.

Authors:  Xian-Feng Shi; Douglas G Kondo; Young-Hoon Sung; Tracy L Hellem; Kristen K Fiedler; Eun-Kee Jeong; Rebekah S Huber; Perry F Renshaw
Journal:  Bipolar Disord       Date:  2012-07-20       Impact factor: 6.744

Review 3.  Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications.

Authors:  Tadafumi Kato
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 4.  Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia.

Authors:  Hayley B Clay; Stephanie Sillivan; Christine Konradi
Journal:  Int J Dev Neurosci       Date:  2010-09-15       Impact factor: 2.457

5.  Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness.

Authors:  Yi Che; Jun-Feng Wang; Li Shao; Trevor Young
Journal:  J Psychiatry Neurosci       Date:  2010-09       Impact factor: 6.186

Review 6.  Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics.

Authors:  Robin Ortiz; Henning Ulrich; Carlos A Zarate; Rodrigo Machado-Vieira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-11-07       Impact factor: 5.067

7.  Unchanged packing density but altered size of neurofilament immunoreactive neurons in the prefrontal cortex in schizophrenia and major depression.

Authors:  Jose Javier Miguel-Hidalgo; Priti Dubey; Qingmei Shao; Craig Stockmeier; Grazyna Rajkowska
Journal:  Schizophr Res       Date:  2005-07-15       Impact factor: 4.939

Review 8.  Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder.

Authors:  Rafael T de Sousa; Rodrigo Machado-Vieira; Carlos A Zarate; Husseini K Manji
Journal:  Expert Opin Ther Targets       Date:  2014-07-24       Impact factor: 6.902

9.  Neurochemical abnormalities in unmedicated bipolar depression and mania: a 2D 1H MRS investigation.

Authors:  Jun Xu; Ulrike Dydak; Jaroslaw Harezlak; Jonathan Nixon; Mario Dzemidzic; Abigail D Gunn; Harish S Karne; Amit Anand
Journal:  Psychiatry Res       Date:  2013-06-27       Impact factor: 3.222

10.  Energetic and cell membrane metabolic products in patients with primary insomnia: a 31-phosphorus magnetic resonance spectroscopy study at 4 tesla.

Authors:  David G Harper; David T Plante; J Eric Jensen; Caitlin Ravichandran; Orfeu M Buxton; Kathleen L Benson; Shawn P O'Connor; Perry F Renshaw; John W Winkelman
Journal:  Sleep       Date:  2013-04-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.